These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 20538166
21. Predictors of coronary heart disease events among asymptomatic persons with low low-density lipoprotein cholesterol MESA (Multi-Ethnic Study of Atherosclerosis). Blankstein R, Budoff MJ, Shaw LJ, Goff DC, Polak JF, Lima J, Blumenthal RS, Nasir K. J Am Coll Cardiol; 2011 Jul 19; 58(4):364-74. PubMed ID: 21757113 [Abstract] [Full Text] [Related]
22. Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors. Fernández-Friera L, Fuster V, López-Melgar B, Oliva B, García-Ruiz JM, Mendiguren J, Bueno H, Pocock S, Ibáñez B, Fernández-Ortiz A, Sanz J. J Am Coll Cardiol; 2017 Dec 19; 70(24):2979-2991. PubMed ID: 29241485 [Abstract] [Full Text] [Related]
23. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study). Robinson JG, Ballantyne CM, Hsueh W, Rosen J, Lin J, Shah A, Lowe RS, Hanson ME, Tershakovec AM. J Clin Lipidol; 2011 Dec 19; 5(6):474-82. PubMed ID: 22108151 [Abstract] [Full Text] [Related]
24. Peripheral arterial disease and progression of coronary atherosclerosis. Hussein AA, Uno K, Wolski K, Kapadia S, Schoenhagen P, Tuzcu EM, Nissen SE, Nicholls SJ. J Am Coll Cardiol; 2011 Mar 08; 57(10):1220-5. PubMed ID: 21371639 [Abstract] [Full Text] [Related]
25. Predictive value of lipid profile for salutary coronary angiographic changes in patients on a low-fat diet and physical exercise program. Niebauer J, Hambrecht R, Velich T, Marburger C, Hauer K, Kreuzer J, Zimmermann R, von Hodenberg E, Schlierf G, Schuler G, Kübler W. Am J Cardiol; 1996 Jul 15; 78(2):163-7. PubMed ID: 8712137 [Abstract] [Full Text] [Related]
26. Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial. Nissen SE, Nicholls SJ, Wolski K, Rodés-Cabau J, Cannon CP, Deanfield JE, Després JP, Kastelein JJ, Steinhubl SR, Kapadia S, Yasin M, Ruzyllo W, Gaudin C, Job B, Hu B, Bhatt DL, Lincoff AM, Tuzcu EM, STRADIVARIUS Investigators. JAMA; 2008 Apr 02; 299(13):1547-60. PubMed ID: 18387931 [Abstract] [Full Text] [Related]
27. Stabilization of carotid atheroma assessed by quantitative ultrasound analysis in nonhypercholesterolemic patients with coronary artery disease. Watanabe K, Sugiyama S, Kugiyama K, Honda O, Fukushima H, Koga H, Horibata Y, Hirai T, Sakamoto T, Yoshimura M, Yamashita Y, Ogawa H. J Am Coll Cardiol; 2005 Dec 06; 46(11):2022-30. PubMed ID: 16325036 [Abstract] [Full Text] [Related]
28. Relation between plaque progression and low-density lipoprotein cholesterol during aging as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound of the left main coronary artery. Hartmann M, von Birgelen C, Mintz GS, van Houwelingen GK, Eggebrecht H, Böse D, Wieneke H, Verhorst PM, Erbel R. Am J Cardiol; 2006 Dec 01; 98(11):1419-23. PubMed ID: 17126642 [Abstract] [Full Text] [Related]
29. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study. Bonnet J, McPherson R, Tedgui A, Simoneau D, Nozza A, Martineau P, Davignon J, CAP Investigators. Clin Ther; 2008 Dec 01; 30(12):2298-313. PubMed ID: 19167589 [Abstract] [Full Text] [Related]
30. Do the extent and direction of arterial remodelling predict subsequent progression of coronary atherosclerosis? A serial intravascular ultrasound study. Sipahi I, Tuzcu EM, Moon KW, Nicholls SJ, Schoenhagen P, Zhitnik J, Crowe TD, Kapadia S, Nissen SE. Heart; 2008 May 01; 94(5):623-7. PubMed ID: 18070944 [Abstract] [Full Text] [Related]
31. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort. Clearfield MB, Weis SE, Willis JM, Vasenius KA, McConathy WJ. J Am Osteopath Assoc; 2002 Jul 01; 102(7):377-84. PubMed ID: 12138952 [Abstract] [Full Text] [Related]
32. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial. Schoenhagen P, Tuzcu EM, Apperson-Hansen C, Wang C, Wolski K, Lin S, Sipahi I, Nicholls SJ, Magyar WA, Loyd A, Churchill T, Crowe T, Nissen SE. Circulation; 2006 Jun 20; 113(24):2826-34. PubMed ID: 16769916 [Abstract] [Full Text] [Related]
33. Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy. Puri R, Nissen SE, Shao M, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Libby P, Raichlen JS, Uno K, Kataoka Y, Nicholls SJ. Eur Heart J; 2013 Nov 20; 34(41):3182-90. PubMed ID: 23886915 [Abstract] [Full Text] [Related]
34. Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease. Elshazly MB, Mani P, Nissen S, Brennan DM, Clark D, Martin S, Jones SR, Quispe R, Donnellan E, Nicholls SJ, Puri R. Eur J Prev Cardiol; 2020 Jul 20; 27(10):1091-1100. PubMed ID: 31744333 [Abstract] [Full Text] [Related]
35. Relation between lipoprotein(a) and fibrinogen and serial intravascular ultrasound plaque progression in left main coronary arteries. Hartmann M, von Birgelen C, Mintz GS, Stoel MG, Eggebrecht H, Wieneke H, Fahy M, Neumann T, van der Palen J, Louwerenburg HW, Verhorst PM, Erbel R. J Am Coll Cardiol; 2006 Aug 01; 48(3):446-52. PubMed ID: 16875967 [Abstract] [Full Text] [Related]
36. Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: the atherosclerosis risk in communities study. Muntner P, Lee F, Astor BC. Am J Med Sci; 2011 Mar 01; 341(3):173-80. PubMed ID: 21042169 [Abstract] [Full Text] [Related]
37. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial). Goldenberg I, Benderly M, Sidi R, Boyko V, Tenenbaum A, Tanne D, Behar S. Am J Cardiol; 2009 Jan 01; 103(1):41-5. PubMed ID: 19101227 [Abstract] [Full Text] [Related]
38. Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. Nicholls SJ, Tuzcu EM, Kalidindi S, Wolski K, Moon KW, Sipahi I, Schoenhagen P, Nissen SE. J Am Coll Cardiol; 2008 Jul 22; 52(4):255-62. PubMed ID: 18634979 [Abstract] [Full Text] [Related]
39. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance. Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S. Clin Ther; 2008 Jun 22; 30(6):1089-101. PubMed ID: 18640465 [Abstract] [Full Text] [Related]
40. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010. Wong ND, Chuang J, Zhao Y, Rosenblit PD. J Clin Lipidol; 2015 Jun 22; 9(4):525-32. PubMed ID: 26228670 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]